Optimising treatment for patients in the vulnerable phase.

26 May 2019 (12:48 - 13:06)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

6 More presentations in this session

Presentation thumbnail

Welcome video.

Presentation thumbnail

Welcome and introduction - Treatment choices to optimise benefits for heart failure patients.

Professor F. Ruschitzka (Zurich, CH)

Presentation thumbnail

How to achieve the optimisation we aim for.

Professor M. Senni (Bergamo, IT)

Presentation thumbnail

Personalising care for heart failure patients.

Professor J. McMurray (Glasgow, GB)

Presentation thumbnail

Panel discussion - Treatment choices to optimise benefits for heart failure patients.

Professor J. McMurray (Glasgow, GB) Professor F. Ruschitzka (Zurich, CH) Professor M. Senni (Bergamo, IT) Professor J. Butler (Dallas, US)

Access the full session

Session thumbnail

Treatment choices to optimise benefits for heart failure patients

The Event

Heart Failure 2019

26 May 2019 12:48 CET

You may be interested in

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

19 July 2023

Congress Presentation

Assessing the achievability of optimal therapy in patients with heart failure with reduced ejection fraction; a difficult task?

20 May 2023

Congress Presentation

Optimising treatment decisions: why speed of effect matters in ATTR-CM

28 August 2026

Congress Presentation

Only 1 in 5 european HF centres "always" initiate all four GDMT pillars during hospitalisation despite near-universal IV iron and uptitration capacity

30 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources